Patent Anticipation – 35 U.S.C. § 102; Novelty – 35 U.S.C. § 103; and Patent-eligible subject matter – 35 U.S.C. § 101.

Patent Anticipation - 35 U.S.C. § 102; Novelty - 35 U.S.C. § 103; and Patent-eligible subject matter - 35 U.S.C. § 101. Please join us on Monday, September 29, 2025, at noon, where we will discuss a recent decisions made by the Court of Appeals for the Federal Circuit regarding patent anticipation – section 102, [...]

AIT v Salesforce – war story update

Patent suits can be like the War of the Roses, or Bleak House. Though most patent suits end pretty quickly, high value cases often pend for a long time. Our firm represents a patent owner in one such suit. Bleak House cover In November 2013, our client Applications in Internet Time, LLC sued [...]

Federal Circuit Dismantles “Rigid” Rosen-Durling Test for Design Patent Obviousness in Light of KSR; USPTO Promptly Issues New Guidance

Federal Circuit Dismantles “Rigid” Rosen-Durling Test for Design Patent Obviousness in Light of KSR; USPTO Promptly Issues New Guidance On February 5, 2024, the Federal Circuit sat en banc to hear oral arguments in a closely watched case concerning design patent obviousness standards in a dispute between LKQ (an aftermarket auto-parts provider), and General Motors [...]

CAFC re: Recapture During a Broadening Reissue; and CAFC re: Expert Witnesses and Obviousness

SoCal IP Law Institute MCLE meeting of August 15, 2022 - CAFC re: Recapture During a Broadening Reissue; and CAFC re: Expert Witnesses and Obviousness. Please join us on Monday, August 15, 2022 at Noon , where we will discuss CAFC re: Recapture During a Broadening Reissue; and CAFC re: Expert Witnesses and Obviousness. For [...]

Inherency of Negative Claim terms and Trade Dress in the 5th Circuit

Please join us on Monday, August 8, 2022 at 12:00 pm, where we will discuss the following: Novartis Pharm. Corp. v. Accord Healthcare, Inc., 38 F.4th 1013 (Fed. Cir. 2022) (rehearing decision here) - Novartis prevailed in the 5th Circuit on the validity of its claims under the Written Description Requirement based on a negative [...]

CAFC re: Intrinsic Evidence on Indefiniteness and Sanctions; and CAFC re: Damages Calculation.

Please join us on Monday, June 13, 2022 at 12:00 pm, where we will discuss recent Court of Appeals for the Federal Circuit action regarding Intrinsic Evidence on Indefiniteness and Sanctions; and regarding Damages Calculation. For CAFC Clarifies Analysis of Intrinsic Evidence on Indefiniteness, Affirms PTAB’s Denial of Sanctions, please see: ClearOne v Shure. For [...]

Supreme Court to Clarify Transformative Use in Andy Warhol Foundation v. Goldsmith; CAFC Muddies Standing Requirements for TTAB Appeals

On Monday, April 11, 2022, Chris Kopitzke will lead a discussion of the issues before the Supreme Court in the long-running copyright infringement case based on Andy Warhol’s “Prince” series of artworks, and about the CAFC’s recent holding that a party lacked Article III standing to challenge the TTAB’s ruling on likelihood of confusion involving [...]

By |2022-04-09T12:46:26-07:00April 9th, 2022|indefiniteness, Invalidity, Written Description|0 Comments

Two Recent Federal Circuit Cases

Please join us on Monday, March 28, 2022 at 12:00 pm, where we will discuss two recent Court of Appeals for the Federal Circuit decisions. Dyfan, LLC v. Target Corp., No. 21-1725 (Fed. Cir. 2022) addresses claim construction to determine whether a patent is invalid.  The evaluation includes consideration of whether patent claims adhere to [...]

An Honest Conversation about Alcohol: Navigating Holidays and Celebrations

Please join us on Monday, January 13, 2025 at 12:00 pm, where we will watch a Substance Abuse MCLE video entitled -An Honest Conversation about Alcohol: Navigating Holidays and Celebrations. The video is presented by the D.C. Bar Lawyer Assistance Program on November 14, 2023. The video link is pasted below. https://www.youtube.com/watch?v=iBE3ap0b0Dk Angelo Gaz, of [...]

Go to Top